By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Enterome, a privately held biomarker development firm, has raised €5 million ($6.6 million) in a series A round of private funding, it said Thursday.
Registering provides access to this and other free content.
Already have an account?Login Now.
An Australian study of personalized medicine has run into problems as it recruits patients.
In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.
The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.
The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.
This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.